市場調査レポート

商品コード

塞栓療法市場の2028年までの予測-製品、疾患適応、施術、エンドユーザー別の世界分析

Embolotherapy Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product, Disease Indication, Procedure, and End User

出版日: 2022年08月11日 | 発行: The Insight Partners

| ページ情報: 英文 255 Pages | 納期: 即納可能

価格

PDF (Single User License)

USD 4,550 714,987円

レポートPDFを1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は一度のみ可能です。印刷したもののご利用はPDFのライセンス保持者に限定されます。

PDF (Site License)

USD 6,550 1,029,267円

レポートPDFを同一事業所（所在地）内のすべての方にご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 8,550 1,343,547円

レポートPDFを企業内すべての方に使用頂けるライセンスです。PDF内のテキスト等のコピーは可能です。PDFの印刷回数に制限はありません。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=157.14円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

塞栓療法市場は、2021年の33億4149万米ドルから2028年には57億5828万米ドルに成長すると予測され、2022年から2028年までのCAGRは8.1%と推定されています。

当レポートでは、市場に蔓延する動向と塞栓療法市場の成長を促進する要因について取り上げています。市場の成長は、癌患者の発生率の上昇、低侵襲処置に対する患者の嗜好の高まり、高血圧、肥満、喫煙、アルコール依存症の発生率の上昇に起因しています。しかし、他の代替療法が利用可能であることや、塞栓剤のコストが高いことが、市場の成長を制限しています。

塞栓療法は、血管造影用カテーテルを用いてバルーン、血栓、コイル、ジェルフォームを導入し、動脈を閉塞させる治療法です。カテーテルは、出血性潰瘍の治療、瘻孔や動静脈奇形の閉鎖、臓器の脱血管、血管欠損、手術不能な出血の制御のためにバルーンやあらゆる異物を埋め込んで血管を塞ぐことを補助するものです。また、手術中に腫瘍に向かう血流や腫瘍周辺の血流を止めるために、塞栓療法が行われることもあります。

がんの種類は、乳がん、前立腺がん、子宮頸がん、肺がん、大腸がんの5つが代表的なものです。しかし、この5つのがんのうち、がんに関連する死因の第1位は肺がんです。乳がんは女性の発生率が少なくとも25％高いにもかかわらず、子宮頸がんは2020年の死因の第1位でした。National Cancer Registry（NCR）によると、2020年には南アフリカで～110,000人の新規がん患者が診断され、56,000人以上のがん関連死が発生し、非感染性疾患関連の早期死亡の4分の1を占めます。この重大ながんの負担は今後数十年で増加すると予測され、新規のがん症例の発生率は、2030年には138,000件、2040年には175,000件に増加すると予想されています。また、がん関連死亡率は、同期間に73,000人と94,000人に増加することが予測されています。さらに、米国癌学会誌によると、2021年には米国で新たに190万人の癌患者が診断され、608,570人が癌で死亡すると推定されています。さらに、デンマークでは、男女を合わせたがん罹患率が最も高く、10万人あたり334.9人でした。年齢標準化率が10万人あたり300人以上だったのは、10カ国です。デンマーク、ハンガリー、アイルランド、ベルギー、フランス、オーストラリア、オランダ、ノルウェー、フランス（ニューカレドニア）、スロベニア。2018年、ドイツでは女性233,000人、男性265,000人が新たにがんと診断されたと推定されています。年間の新規罹患者総数は、約10年間、約50万人で停滞しています。このように、がん患者の増加により、塞栓療法製品の高い需要が生まれています。

塞栓療法市場は、製品によって塞栓剤とサポートデバイスに二分されます。塞栓剤は、さらにマイクロスフィア、液体塞栓剤、塞栓コイル、塞栓プラグシステム、剥離性バルーン、その他に細分化されます。サポートデバイスは、さらにマイクロカテーテルとガイドワイヤーに分類されます。2021年には、塞栓剤セグメントが最大の市場シェアを占めると思われます。さらに、同セグメントは予測期間中に最も高いCAGRを記録すると予測されます。塞栓剤セグメントの成長の主な推進要因は、さまざまなインターベンショナルラジオロジー手順における塞栓剤の使用の増加と塞栓剤の進歩です。

塞栓療法市場は、適応疾患に基づいて、がん、末梢血管疾患、神経疾患、泌尿器・腎臓疾患、消化器疾患、その他に分類されます。がんは、肝がん、腎がん、その他に細分化されます。2021年には、がんセグメントが最大の市場シェアを占めると思われます。さらに、同セグメントは2022年から2028年にかけて最も速いCAGRを記録すると予想されます。がんセグメントの成長の主な推進要因は、世界のがんの発生率の上昇です。

塞栓療法市場は、疾患適応に基づき、経カテーテル動脈塞栓術（TAE）、経カテーテル動脈放射線塞栓術（TARE）/選択的内部放射線療法（SIRT）、経動脈化学塞栓術（TACE）に区分されます。2021年には、経カテーテル動脈塞栓術（TAE）セグメントが最大の市場シェアを占めると思われます。さらに、同セグメントは2022年から2028年にかけて最も速いCAGRを記録すると予測されます。経カテーテル動脈塞栓術（TAE）セグメントの成長の主な推進要因は、高齢者による低侵襲処置への嗜好の高まり、慢性疾患の有病率の増加、老年人口の急速な増加などです。

塞栓療法市場は、エンドユーザーに基づいて、病院＆クリニック、外来手術センター、その他のエンドユーザーに区分されます。2021年には、病院・診療所セグメントが市場の最大シェアを占めると思われます。さらに、同セグメントは2022年から2028年にかけて最も高いCAGRを記録すると予測されます。病院・診療所セグメントの成長の主な推進要因は、低侵襲外科手術（血管、泌尿器、神経を含む）の採用拡大、癌などの各種疾患の治療のために病院に訪れる患者の増加、これらの施設で行われる塞栓処置の増加、大きな病院、小さな診療所、重症患者病棟で複雑な処置を正確に行うための高度で最先端の塞栓療法装置の採用拡大などです。

COVID-19の影響- 塞栓療法市場

このような状況の中、頭頸部外科手術などの癌、脳動脈瘤などの慢性神経疾患、頭痛から神経変性疾患まで、その管理には多大な困難が伴うことが分かってきています。そのため、がんや神経疾患の症状が悪化し、救急外来に入院する患者も少なくありません。COVID-19の大流行時には、がんや脳卒中などの神経疾患の患者さんが、急性期介入の治療枠外に遅れて病院へ到着することがありました。また、急性期の疾患を管理するための集中治療室のベッドを確保することも困難な状況に陥りました。

その結果、当初は病院での待機的な手術や処置がすべてキャンセルされることになりました。子宮筋腫は通常、脅かされることはありませんが、一部の患者さんの生活の質には大きな影響がありました。このように、ウイルスの相互感染を抑えるため、あるいは感染した患者を支援するための病院の体制を予定するために、選択的な治療へのアクセスに制約が課されたため、女性は不快感やわずかな効果の一時的な治療とともに生活することになりました。そのため、病院や公的機関ではCOVID-19の流行期間中も子宮筋腫塞栓術（UFE）を継続して行ってきました。これらの要因は、初期には市場成長にマイナスの影響を与えると思われました。

塞栓療法市場では、さまざまな有機的・無機的戦略が企業によって採用されています。有機的戦略は、主に製品の上市と製品承認を含んでいます。さらに、市場で示された無機的な成長戦略は、買収、コラボレーション、およびパートナーシップです。これらの成長戦略は、塞栓療法市場のプレーヤーが事業を拡大し、地理的プレゼンスを強化し、それによって市場全体の成長に貢献することを可能にします。さらに、買収とパートナーシップ戦略は、市場プレーヤーが顧客基盤を強化し、その製品ポートフォリオを拡大するのに役立ちます。塞栓療法市場の主要企業によるいくつかの重要な発展を以下に示します。

2022年4月、ボストン・サイエンティフィック社は、末梢血管の血流を阻害または減少させることを目的としたEMBOLD Fibered Detachable Coilについて米国食品医薬品局（FDA）から510（k）認可を取得しました。ボストン・サイエンティフィックのインターベンショナル・オンコロジー・ポートフォリオに新たに加わったEMBOLD Fibered Coilは、1本または複数の血管を塞いで血流を阻害または減少させることを目的とした低侵襲治療である各種塞栓術に使用するために設計されたものです。

2021年9月、アボット社は、末梢血栓を除去するために設計された低侵襲の機械的吸引血栓除去システムを有する商業段階の医療機器企業であるWalk Vascular, LLCを買収したと発表しました。ウォークバスキュラー社の末梢血栓除去システムは、アボット社の既存の血管内治療製品ポートフォリオに組み込まれる予定です。

塞栓療法市場に関する報告書の作成にあたり、世界保健機関（WHO）、米国疾病管理センター（CDC）、英国製薬工業協会（ABPI）などの主要な一次情報および二次情報を参照しています。

調査対象範囲
インサイトパートナーズの調査報告書ガイダンス
市場セグメンテーション
- 塞栓療法の世界市場-製品別
- 塞栓療法の世界市場- 疾患適応症別
- 塞栓療法の世界市場-処置別
- 塞栓療法の世界市場-エンドユーザー別
- 塞栓療法の世界市場-地域別

第2章塞栓療法市場-主要なポイント

第3章調査手法

適用範囲
2次調査
1次調査

第4章世界の塞栓療法市場- 市場情勢

PEST分析
- 北米-PEST分析
- 欧州-PEST分析
- アジア太平洋-PEST分析
- 中東・アフリカ-PEST分析
- 中南米-PEST分析
専門家の見解

第5章塞栓療法市場-主要な市場力学

市場促進要因
- 癌患者の発生率の増加
- 低侵襲手術に対する患者の嗜好の高まり
- 高血圧、肥満、喫煙、アルコール依存症の発生率の増加
市場抑制要因
- 他の代替療法の利用可能性
- 塞栓療法にかかる高いコスト
市場機会
- 塞栓療法の用途の拡大
市場動向
- 液状塞栓薬の使用増加
インパクト分析

第6章塞栓療法市場-世界分析

塞栓療法の世界市場収益と予測・分析
塞栓療法の世界市場、地域別予測・分析
- 塞栓療法の世界市場-市場ポテンシャル分析、地域別
主要プレイヤーの市場ポジショニング
- 企業分析
- 成長戦略分析
- 主要プレイヤーの業績
  - クックメディカルLLC
  - ボストン・サイエンティフィック社

第7章塞栓療法市場の収益と2028年までの製品別予測

塞栓療法市場の製品別収益シェア（2022年・2028年）（%）
塞栓剤
サポートデバイス

第8章塞栓療法市場分析- 疾患適応別

塞栓療法市場収益シェア、疾患適応別2022年 &2028年（%）
癌
末梢血管疾患
神経系疾患
泌尿器・腎臓疾患
消化器系疾患
その他

第9章塞栓療法市場の分析- 施術別

塞栓療法市場の収益シェア（処置別）2022年・2028年（%）
経カテーテル動脈塞栓術（TAE）
経カテーテル動脈塞栓術（TARE）/選択的内部放射線療法（SIRT）
経動脈的化学塞栓療法（TACE）

第10章塞栓療法市場の分析- エンドユーザー別

塞栓療法市場のエンドユーザー別収益シェア（2022年、2028年）（%）
病院および診療所
外来手術センター
その他のエンドユーザー

第11章塞栓療法市場- 地域別分析

北米
- 米国
- カナダ
- メキシコ
欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- その他欧州
アジア太平洋地域
- 中国
- 日本
- インド
- 韓国
- オーストラリア
- その他アジア太平洋地域
中東・アフリカ地域
- サウジアラビア
- 南アフリカ共和国
- UAE
- その他の中東・アフリカ地域
中南米地域
- ブラジル
- アルゼンチン
- その他の中南米地域

第12章 COVID-19のパンデミックが世界の塞栓療法市場に与える影響

北米
欧州
アジア太平洋地域
中東＆アフリカ
中南米

第13章塞栓療法市場-業界情勢

市場参入企業が行った成長戦略（%）
有機的開発
無機的開発

第14章企業プロファイル

Abbott Laboratories
Boston Scientific Corporation
Cook Medical LLC
Johnson & Johnson
Medtronic
Acandis GmbH
Balt USA LLC
Stryker Corporation
Guerbet LLC

図表

List Of Tables

Table 1. North America Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 2. North America Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
Table 3. North America Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
Table 4. North America Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
Table 5. North America Embolotherapy Market, by Cancer- Revenue and Forecast to 2028 (US$ Million)
Table 6. North America Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
Table 7. North America Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
Table 8. US Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 9. US Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
Table 10. US Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
Table 11. US Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
Table 12. US Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
Table 13. US Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
Table 14. US Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
Table 15. Canada Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 16. Canada Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
Table 17. Canada Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
Table 18. Canada Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
Table 19. Canada Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
Table 20. Canada Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
Table 21. Canada Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
Table 22. Mexico Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 23. Mexico Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
Table 24. Mexico Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
Table 25. Mexico Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
Table 26. Mexico Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
Table 27. Mexico Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
Table 28. Mexico Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
Table 29. Europe Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 30. Europe Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
Table 31. Europe Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
Table 32. Europe Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
Table 33. Europe Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
Table 34. Europe Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
Table 35. Europe Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
Table 36. Germany Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 37. Germany Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
Table 38. Germany Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
Table 39. Germany Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
Table 40. Germany Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
Table 41. Germany Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
Table 42. Germany Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
Table 43. France Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 44. France Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
Table 45. France Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
Table 46. France Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
Table 47. France Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
Table 48. France Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
Table 49. France Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
Table 50. UK, Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 51. UK, Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
Table 52. UK, Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
Table 53. UK, Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
Table 54. UK, Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
Table 55. UK, Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
Table 56. UK, Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
Table 57. Italy Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 58. Italy Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
Table 59. Italy Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
Table 60. Italy Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
Table 61. Italy Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
Table 62. Italy Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
Table 63. Italy Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
Table 64. Spain Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 65. Spain Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
Table 66. Spain Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
Table 67. Spain Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
Table 68. Spain Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
Table 69. Spain Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
Table 70. Spain Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
Table 71. Rest of Europe Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 72. Rest of Europe Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
Table 73. Rest of Europe Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
Table 74. Rest of Europe Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
Table 75. Rest of Europe Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
Table 76. Rest of Europe Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
Table 77. Rest of Europe Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
Table 78. Asia Pacific: Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 79. Asia Pacific Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
Table 80. Asia Pacific Embolotherapy Market, by Support Device - Revenue and Forecast to 2028 (US$ Million)
Table 81. Asia Pacific Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
Table 82. Asia Pacific Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
Table 83. Asia Pacific Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
Table 84. Asia Pacific Embolotherapy Market, by End User- Revenue and Forecast to 2028 (US$ Million)
Table 85. China Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 86. China Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
Table 87. China Embolotherapy Market, by Support Device - Revenue and Forecast to 2028 (US$ Million)
Table 88. China Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
Table 89. China Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
Table 90. China Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
Table 91. China Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
Table 92. Japan Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 93. Japan Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
Table 94. Japan Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
Table 95. Japan Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
Table 96. Japan Embolotherapy Market, by Cancer- Revenue and Forecast to 2028 (US$ Million)
Table 97. Japan Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
Table 98. Japan Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
Table 99. India: Embolotherapy Market, By Product - Revenue And Forecast To 2028 (US$ Million)
Table 100. India: Embolotherapy Market, By Embolic Agents - Revenue And Forecast To 2028 (US$ Million)
Table 101. India: Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
Table 102. India: Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
Table 103. India: Embolotherapy Market, by Cancer- Revenue and Forecast to 2028 (US$ Million)
Table 104. India: Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
Table 105. India: Embolotherapy Market, By End User- Revenue And Forecast To 2028 (US$ Million)
Table 106. South Korea: Embolotherapy Market, By Product - Revenue And Forecast To 2028 (US$ Million)
Table 107. South Korea: Embolotherapy Market, By Embolic Agents - Revenue And Forecast To 2028 (US$ Million)
Table 108. South Korea: Embolotherapy Market, By Support Devices - Revenue And Forecast To 2028 (US$ Million)
Table 109. South Korea: Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
Table 110. South Korea: Embolotherapy Market, by Cancer- Revenue and Forecast to 2028 (US$ Million)
Table 111. South Korea: Embolotherapy Market, By Procedure - Revenue And Forecast To 2028 (US$ Million)
Table 112. South Korea: Embolotherapy Market, By End User- Revenue And Forecast To 2028 (US$ Million)
Table 113. Australia: Embolotherapy Market, By Product - Revenue And Forecast To 2028 (US$ Million)
Table 114. Australia: Embolotherapy Market, By Embolic Agents - Revenue And Forecast To 2028 (US$ Million)
Table 115. Australia: Embolotherapy Market, By Support Devices - Revenue And Forecast To 2028 (US$ Million)
Table 116. Australia: Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
Table 117. Australia: Embolotherapy Market, by Cancer- Revenue and Forecast to 2028 (US$ Million)
Table 118. Australia: Embolotherapy Market, By Procedure - Revenue And Forecast To 2028 (US$ Million)
Table 119. Australia: Embolotherapy Market, By End User- Revenue And Forecast To 2028 (US$ Million)
Table 120. Rest of Asia Pacific: Embolotherapy Market, By Product - Revenue And Forecast To 2028 (US$ Million)
Table 121. Rest of Asia Pacific: Embolotherapy Market, By Embolic Agents - Revenue And Forecast To 2028 (US$ Million)
Table 122. Rest of Asia Pacific: Embolotherapy Market, By Support Devices - Revenue And Forecast To 2028 (US$ Million)
Table 123. Rest of Asia Pacific: Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
Table 124. Rest of Asia Pacific: Embolotherapy Market, by Cancer- Revenue and Forecast to 2028 (US$ Million)
Table 125. Rest of Asia Pacific: Embolotherapy Market, By Procedure - Revenue And Forecast To 2028 (US$ Million)
Table 126. Rest Of Asia Pacific: Embolotherapy Market, By End User- Revenue And Forecast To 2028 (US$ Million)
Table 127. Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million).
Table 128. Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)
Table 129. Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)
Table 130. Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)
Table 131. Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)
Table 132. Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)
Table 133. Middle East & Africa: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 134. Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)
Table 135. Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)
Table 136. Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)
Table 137. Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)
Table 138. Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)
Table 139. Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)
Table 140. Saudi Arabia: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 141. South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)
Table 142. South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)
Table 143. South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)
Table 144. South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)
Table 145. South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)
Table 146. South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)
Table 147. South Africa: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 148. UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)
Table 149. UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)
Table 150. UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)
Table 151. UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)
Table 152. UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)
Table 153. UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)
Table 154. UAE: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 155. Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)
Table 156. Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)
Table 157. Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)
Table 158. Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)
Table 159. Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)
Table 160. Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)
Table 161. Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)
Table 162. South and Central America Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 163. South and Central America Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
Table 164. South and Central America Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
Table 165. South and Central America Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
Table 166. South and Central America Embolotherapy Market, by Cancer- Revenue and Forecast to 2028 (US$ Million)
Table 167. South and Central America Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
Table 168. South and Central America Embolotherapy Market, by End User- Revenue and Forecast to 2028 (US$ Million)
Table 169. Brazil Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 170. Brazil Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
Table 171. Brazil Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
Table 172. Brazil Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
Table 173. Brazil Embolotherapy Market, by Cancer- Revenue and Forecast to 2028 (US$ Million)
Table 174. Brazil Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
Table 175. Brazil Embolotherapy Market, by End User- Revenue and Forecast to 2028 (US$ Million)
Table 176. Argentina Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 177. Argentina Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
Table 178. Argentina Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
Table 179. Argentina Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
Table 180. Argentina Embolotherapy Market, by Cancer- Revenue and Forecast to 2028 (US$ Million)
Table 181. Argentina Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
Table 182. Argentina Embolotherapy Market, by End User- Revenue and Forecast to 2028 (US$ Million)
Table 183. Rest of South and Central America Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
Table 184. Rest of South and Central America Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
Table 185. Rest of South and Central America Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
Table 186. Rest of South and Central America Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
Table 187. Rest of South and Central America Embolotherapy Market, by Cancer- Revenue and Forecast to 2028 (US$ Million)
Table 188. Rest of South and Central America Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
Table 189. Rest of South and Central America Embolotherapy Market, by End User- Revenue and Forecast to 2028 (US$ Million)
Table 190. Organic Developments Done By Companies
Table 191. Inorganic Developments Done by Companies
Table 192. Glossary of Terms, Embolotherapy Market

List Of Figures

Figure 1. Global Embolotherapy Market Segmentation
Figure 2. Embolotherapy Market, By Region
Figure 3. Embolotherapy Market Overview
Figure 4. Embolic Agents Held Largest Share of Product Segment in Embolotherapy Market
Figure 5. Embolotherapy Market in Asia Pacific Region to Show Remarkable Growth During Forecast Period
Figure 6. Global Embolotherapy Market, By Geography (US$ Million)
Figure 7. Global Embolotherapy Market- Leading Country Markets (US$ Million)
Figure 8. Global Embolotherapy Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East & Africa PEST Analysis
Figure 13. South and Central America PEST Analysis
Figure 14. Embolotherapy Market Impact Analysis of Drivers and Restraints
Figure 15. Global Embolotherapy Market- Revenue Forecast and Analysis - 2020- 2028
Figure 16. Global Embolotherapy Market- By Geography Forecast and Analysis - 2022 & 2028
Figure 17. Global Embolotherapy Market - Market Potential Analysis, By Region
Figure 18. Market Positioning of Key Players in Global Embolotherapy Market
Figure 19. Global Embolotherapy Market - Comparative Company Analysis
Figure 20. Global Embolotherapy Market - Growth Strategy Analysis
Figure 21. Embolotherapy Market Revenue Share, by Products 2022 & 2028 (%)
Figure 22. Embolic Agents: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
Figure 23. Microspheres: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
Figure 24. Embolic Coils: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
Figure 25. Embolic Plug Systems: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
Figure 26. Detachable Balloons: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
Figure 27. Liquid Embolics: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
Figure 28. Others: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
Figure 29. Support Devices: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
Figure 30. Microcatheters: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
Figure 31. Guidewires: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
Figure 32. Embolotherapy Market Revenue Share, by Disease Indication 2022 & 2028 (%)
Figure 33. Cancer: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 34. Liver Cancer: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 35. Kidney Cancer: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 36. Other Cancers: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 37. Peripheral Vascular Diseases: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 38. Neurological Diseases: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 39. Urological and Nephrological Disorders: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 40. Gastrointestinal Disorders: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 41. Others: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 42. Embolotherapy Market Revenue Share, by Procedure 2022 & 2028 (%)
Figure 43. Transcatheter Arterial Embolization (TAE): Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 44. Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT): Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 45. Transarterial Chemoembolization (TACE): Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 46. Embolotherapy Market Revenue Share, By End User 2022 & 2028 (%)
Figure 47. Hospitals: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 48. Ambulatory Surgical Centers: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 49. Other End Users: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 50. North America: Embolotherapy Market, by Key Country - Revenue (2022) (US$ Million)
Figure 51. North America Embolotherapy Market Revenue and Forecast to 2028 (US$ Million)
Figure 52. North America: Embolotherapy Market, by Country, 2022 & 2028 (%)
Figure 53. US: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 54. Canada: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 55. Mexico: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 56. Europe: Embolotherapy Market, by Key Country - Revenue (2022) (US$ Million)
Figure 57. Europe Embolotherapy Market Revenue and Forecast to 2028 (US$ Million)
Figure 58. Europe: Embolotherapy Market, by Country, 2022 & 2028 (%)
Figure 59. Germany: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 60. France: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 61. UK: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 62. Italy: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 63. Spain: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 64. Rest of Europe: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 65. Asia Pacific: Embolotherapy Market, by Key Country - Revenue (2022) (US$ Million)
Figure 66. Asia Pacific Embolotherapy Market Revenue and Forecast to 2028 (US$ Million)
Figure 67. Asia Pacific: Embolotherapy Market, by Country, 2022 & 2028 (%)
Figure 68. China: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 69. Japan: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 70. India: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
Figure 71. South Korea: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
Figure 72. Australia: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
Figure 73. Rest Of Asia Pacific: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 74. Middle East & Africa: Embolotherapy Market Revenue Overview, by Country, 2022 (US$ Million)
Figure 75. Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
Figure 76. Middle East & Africa Embolotherapy Market Revenue and Forecasts to 2028, By Country (%)
Figure 77. Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
Figure 78. South Africa: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
Figure 79. UAE: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
Figure 80. Rest of Middle East and Africa: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
Figure 81. South and Central America: Embolotherapy Market, by Key Country - Revenue (2022) (US$ Million)
Figure 82. South and Central America Embolotherapy Market Revenue and Forecast to 2028 (US$ Million)
Figure 83. South and Central America: Embolotherapy Market, by Country, 2022 & 2028 (%)
Figure 84. Brazil: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 85. Argentina: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
Figure 86. Rest of South and Central America: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
Figure 87. Impact of COVID-19 Pandemic in North American Country Markets
Figure 88. Impact of COVID-19 Pandemic in European Country Markets
Figure 89. Impact of COVID-19 Pandemic in Asia Pacific Countries
Figure 90. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 91. Impact of COVID-19 Pandemic in South & Central America Countries
Figure 92. Growth Strategies Done by the Companies in the Market, (%)

Product Code: TIPRE00006432

The embolotherapy market is expected to grow from US$ 3,341.49 million in 2021 to US$ 5,758.28 million by 2028; it is estimated to grow at a CAGR of 8.1% from 2022 to 2028.

The report highlights trends prevailing in the market and factors driving the embolotherapy market growth. The market growth is attributed to a rising incidence of cancer cases, rising patient preference for minimally invasive procedures, and increasing incidence of hypertension, obesity, smoking, and alcoholism. However, the availability of other alternative therapies and the high cost of embolization agents limit the market growth.

Embolotherapy is an occlusion of arteries by introducing balloons, blood clots, coils, or gel foam using an angiographic catheter. The catheter aids in blocking a blood vessel by implanting a balloon or any foreign body to treat bleeding ulcers, close fistulae or arteriovenous malformations, devascularize organs, blood vessel defects, or control inoperable hemorrhage. Embolotherapy is also used to stop blood flow towards and around a tumor during surgery.

The five most common types of cancer are breast, prostate, cervical, lung, and colorectal. However, of these five cancers, the leading cause of cancer-related death is lung cancer. Even though breast cancer has at least a 25% higher incidence among women, cervical carcinoma was the leading cause of death in 2020. According to National Cancer Registry (NCR), in 2020, ~110,000 new cancer cases were diagnosed in South Africa, with over 56,000 cancer-related deaths, representing a quarter of premature noncommunicable disease-related mortality. This significant cancer burden is predicted to increase in the coming decades, with the incidence of new cancer cases expected to rise to 138,000 and 175,000 by 2030 and 2040, respectively. Cancer-related mortality is predicted to rise to 73,000 and 94,000 during the same period. Moreover, according to the American Cancer Society journal, in 2021, an estimated 1.9 million new cancer cases will be diagnosed and 608,570 cancer deaths in the United States. Further, in Denmark, the highest cancer rate for men and women combined was 334.9 people per 100,000. The age-standardized rate was at least 300 per 100,000 for ten countries: Denmark, Hungary, Ireland, Belgium, France, Australia, The Netherlands, Norway, France (New Caledonia), and Slovenia. In 2018, an estimated 233,000 women and 265,000 men in Germany were newly diagnosed with cancer. The total number of new cases per year has stagnated at around 500,000 for about ten years. Thus, the rising prevalence of cancer cases is creating a high demand for embolotherapy products.

Based on the product, the embolotherapy market is bifurcated into embolic agents and support devices. The embolic agents are further sub-segmented into microsphere, liquid embolics agents, embolic coils, embolic plug systems, detachable balloons, and others. The support devices are further sub-segmented into microcatheters and guidewires. The embolic agents segment is likely to hold the largest market share in 2021. Moreover, the same segment is anticipated to register the highest CAGR during the forecast period. The major driving factors for the growth of the embolic agents segment are the increasing use of embolic agents in various interventional radiology procedures and advancements in embolic agents.

Based on disease indication, the embolotherapy market is segmented into cancer, peripheral vascular disease, neurological disease, urological and nephrological disorder, gastrointestinal disorder, and others. The cancer is sub-segmented into liver cancer, kidney cancer, and other. The cancer segment is likely to hold the largest market share in 2021. Moreover, the same segment is expected to record the fastest CAGR from 2022 to 2028. The major driving factors for the growth of the cancer segment are the rising incidences of cancer worldwide.

Based on disease indication, the embolotherapy market is segmented into transcatheter arterial embolization (TAE), transcatheter arterial radioembolization (TARE)/selective internal radiation therapy (SIRT), and transarterial chemoembolization (TACE). The transcatheter arterial embolization (TAE) segment is likely to hold the largest market share in 2021. Moreover, the same segment is expected to record the fastest CAGR from 2022 to 2028. The major driving factors for the growth of the transcatheter arterial embolization (TAE) segment are the rising preference for minimally invasive procedures by the elderly, the growing prevalence of chronic diseases, and the rapid growth in the geriatric population.

Based on end user, the embolotherapy market is segmented into hospital & clinic, ambulatory surgical center, and other end user. In 2021, the hospital & clinic segment will likely hold the market's largest share. Moreover, the same segment is expected to register the highest CAGR from 2022 to 2028. The major driving factors for the growth of the hospitals & clinics segment are the growing adoption of minimally invasive surgical procedures (including vascular, urological, and neurological), higher patient footfall in hospitals for the treatment of various diseases such as cancer, an increasing number of embolization procedures performed in these facilities, growing adoption of advance and cutting-edge embolotherapy devices to perform complex procedures with precision in a big hospital, small clinics, and critical care units.

COVID-19 Impact - Embolotherapy Market

In this scenario, the world observed enormous difficulties in managing cancers such as head and neck surgeries, chronic neurological disorders like brain aneurysms, and from headaches to neurodegenerative diseases. Due to inadequate monitoring, many patients are admitted to emergency departments due to decompensation of their cancer and neurological disease. During the COVID-19 pandemic, cancer, stroke patients, and other neurological conditions have been arriving late at the hospital, outside the therapeutic window for acute intervention. In addition, the country also faced difficulties obtaining beds in the intensive care unit to manage the diseases during the acute phase.

The initial result was the cancellation of all elective hospital surgeries and procedures. While uterine fibroids are typically not threatened, some patients' quality of life has been significantly impacted. Thus, the constraints imposed on accessing elective treatments, either to reduce cross-transmission of the virus or to schedule the hospital structure to assist infected patients, have caused women to live with discomfort and temporary treatments with slight effectiveness. For this reason, hospitals and public organizations have continued to offer Uterine Fibroid Embolization (UFE) during the COVID-19 pandemic. These factors were likely to have a negative impact in the initial phase on the market growth.

Various organic and inorganic strategies are adopted by companies in the embolotherapy market. The organic strategies mainly include product launches and product approvals. Further, inorganic growth strategies witnessed in the market are acquisitions, collaboration, and partnerships. These growth strategies allow the embolotherapy market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall market growth. Further, acquisition and partnership strategies help the market players strengthen their customer base and expand their product portfolios. A few significant developments by key players in the embolotherapy market are listed below.

In April 2022, Boston Scientific Corporation received 510(k) clearance from the US Food and Drug Administration (FDA) for the EMBOLD Fibered Detachable Coil intended to impede or reduce blood flow in the peripheral vasculature. The newest addition to the Boston Scientific interventional oncology portfolio, the EMBOLD Fibered Coil, was designed for use in various embolization procedures, a minimally invasive treatment intended to block one or more blood vessels to obstruct or reduce blood flow.

In September 2021, Abbott announced that it acquired Walk Vascular, LLC, a commercial-stage medical device company with a minimally invasive mechanical aspiration thrombectomy system designed to remove peripheral blood clots. Walk Vascular's peripheral thrombectomy systems will be incorporated into Abbott's existing endovascular product portfolio.

A few major primary and secondary sources referred to while preparing the report on the embolotherapy market are the World Health Organization (WHO), the Centers for Disease Control (CDC), and the Association of the British Pharmaceutical Industry (ABPI).

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the global embolotherapy market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global embolotherapy market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth the market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 Global Embolotherapy Market - by Product
- 1.3.2 Global Embolotherapy Market - by Disease Indication
- 1.3.3 Global Embolotherapy Market - by Procedure
- 1.3.4 Global Embolotherapy Market - by End User
- 1.3.5 Global Embolotherapy Market- By Geography

2. Embolotherapy Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Global Embolotherapy Market - Market Landscape

4.1 Overview
4.2 PEST Analysis
- 4.2.1 North America - PEST Analysis
- 4.2.2 Europe- PEST Analysis
- 4.2.3 Asia Pacific- PEST Analysis
- 4.2.4 Middle East & Africa- PEST Analysis
- 4.2.5 South & Central America - PEST Analysis
4.3 Expert Opinion

5. Embolotherapy Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Rising Incidence of Cancer Cases
- 5.1.2 Rising Patient Preference for Minimally Invasive Procedures
- 5.1.3 Increasing Incidence of Hypertension, Obesity, Smoking, and Alcoholism
5.2 Market Restraints
- 5.2.1 Availability of Other Alternative Therapies
- 5.2.2 High Cost of Embolotherapy
5.3 Market Opportunity
- 5.3.1 Growing Applications of Embolotherapy
5.4 Market Trend
- 5.4.1 Increasing Use of Liquid Embolic Agents
5.5 Impact analysis

6. Embolotherapy Market- Global Analysis

6.1 Global Embolotherapy Market Revenue Forecast and Analysis
6.2 Global Embolotherapy Market, By Geography - Forecast and Analysis
- 6.2.1 Global Embolotherapy Market - Market Potential Analysis, By Region
6.3 Market Positioning of Key Players
- 6.3.1 Company Analysis
- 6.3.2 Growth Strategy Analysis
- 6.3.3 Performance Of Key Players
  - 6.3.3.1 Cook Medical LLC
  - 6.3.3.2 Boston Scientific Corporation

7. Embolotherapy Market Revenue and Forecasts To 2028 by Product

7.1 Overview
7.2 Embolotherapy Market Revenue Share, by Products 2022 & 2028 (%)
7.3 Embolic Agents
- 7.3.1 Overview
- 7.3.2 Embolic Agents: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
- 7.3.3 Microspheres
  - 7.3.3.1 Overview
  - 7.3.3.2 Microspheres: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
- 7.3.4 Embolic Coils
  - 7.3.4.1 Overview
  - 7.3.4.2 Embolic Coils: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
- 7.3.5 Embolic Plug Systems
  - 7.3.5.1 Overview
  - 7.3.5.2 Embolic Plug Systems: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
- 7.3.6 Detachable Balloons
  - 7.3.6.1 Overview
  - 7.3.6.2 Detachable Balloons: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
- 7.3.7 Liquid Embolic Agents
  - 7.3.7.1 Overview
  - 7.3.7.2 Liquid Embolic: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
- 7.3.8 Others
  - 7.3.8.1 Overview
  - 7.3.8.2 Others: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
7.4 Support Devices
- 7.4.1 Overview
- 7.4.2 Support Devices: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
- 7.4.3 Microcatheters
  - 7.4.3.1 Overview
  - 7.4.3.2 Microcatheters: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
- 7.4.4 Guidewires
  - 7.4.4.1 Overview
  - 7.4.4.2 Guidewires: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)

8. Embolotherapy Market Analysis - By Disease Indication

8.1 Overview
8.2 Embolotherapy Market Revenue Share, by Disease Indication 2022 & 2028 (%)
8.3 Cancer
- 8.3.1 Overview
- 8.3.2 Cancer: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
  - 8.3.2.1 Liver Cancer
    - 8.3.2.1.1 Overview
    - 8.3.2.1.2 Liver Cancer: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
  - 8.3.2.2 Kidney Cancer
    - 8.3.2.2.1 Overview
    - 8.3.2.2.2 Kidney Cancer: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
  - 8.3.2.3 Other Cancers
    - 8.3.2.3.1 Overview
    - 8.3.2.3.2 Other Cancers: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Peripheral Vascular Diseases
- 8.4.1 Overview
- 8.4.2 Peripheral Vascular Diseases: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Neurological Diseases
- 8.5.1 Overview
- 8.5.2 Neurological Diseases: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Urological and Nephrological Disorders
- 8.6.1 Overview
- 8.6.2 Urological and Nephrological Disorders: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
8.7 Gastrointestinal Disorders
- 8.7.1 Overview
- 8.7.2 Gastrointestinal Disorders: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
8.8 Others
- 8.8.1 Overview
- 8.8.2 Others: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)

9. Embolotherapy Market Analysis - By Procedure

9.1 Overview
9.2 Embolotherapy Market Revenue Share, by Procedure 2022 & 2028 (%)
9.3 Transcatheter Arterial Embolization (TAE)
- 9.3.1 Overview
- 9.3.2 Transcatheter Arterial Embolization (TAE): Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT)
- 9.4.1 Overview
- 9.4.2 Transcatheter Arterial Radioembolization (TARE)/Selective Internal Radiation Therapy (SIRT): Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Transarterial Chemoembolization (TACE)
- 9.5.1 Overview
- 9.5.2 Transarterial Chemoembolization (TACE): Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)

10. Embolotherapy Market Analysis - By End User

10.1 Overview
10.2 Embolotherapy Market Revenue Share, By End User 2022 & 2028 (%)
10.3 Hospitals and Clinics
- 10.3.1 Overview
- 10.3.2 Hospitals: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
10.4 Ambulatory Surgical Centers
- 10.4.1 Overview
- 10.4.2 Ambulatory Surgical Centers: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
10.5 Other End Users
- 10.5.1 Overview
- 10.5.2 Other End Users: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)

11. Embolotherapy Market - Geographic Analysis

11.1 North America: Embolotherapy Market
- 11.1.1 Overview
- 11.1.2 North America: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
- 11.1.3 North America Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  - 11.1.3.1 North America Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
  - 11.1.3.2 North America Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
- 11.1.4 North America Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
  - 11.1.4.1 North America Embolotherapy Market, by Cancer- Revenue and Forecast to 2028 (US$ Million)
- 11.1.5 North America Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
- 11.1.6 North America Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
- 11.1.7 North America: Embolotherapy Market, by Country, 2022 & 2028 (%)
  - 11.1.7.1 US: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.7.1.1 US: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.7.1.2 US Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.7.1.2.1 US Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.7.1.2.2 US Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.7.1.3 US Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.7.1.3.1 US Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.7.1.4 US Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
    - 11.1.7.1.5 US Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
  - 11.1.7.2 Canada: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.7.2.1 Canada: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.7.2.2 Canada Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.7.2.2.1 Canada Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.7.2.2.2 Canada Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.7.2.3 Canada Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.7.2.3.1 Canada Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.7.2.4 Canada Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
    - 11.1.7.2.5 Canada Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
  - 11.1.7.3 Mexico: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.7.3.1 Mexico: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.7.3.2 Mexico Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.7.3.2.1 Mexico Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.7.3.2.2 Mexico Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.7.3.3 Mexico Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.7.3.3.1 Mexico Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
    - 11.1.7.3.4 Mexico Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
    - 11.1.7.3.5 Mexico Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
11.2 Europe: Embolotherapy Market
- 11.2.1 Overview
- 11.2.2 Europe: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
- 11.2.3 Europe Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  - 11.2.3.1 Europe Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
  - 11.2.3.2 Europe Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
- 11.2.4 Europe Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
  - 11.2.4.1 Europe Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
- 11.2.5 Europe Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
- 11.2.6 Europe Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
- 11.2.7 Europe: Embolotherapy Market, by Country, 2022 & 2028 (%)
  - 11.2.7.1 Germany: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.1.1 Germany: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.1.2 Germany Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.1.2.1 Germany Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.1.2.2 Germany Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.1.3 Germany Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.1.3.1 Germany Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.1.4 Germany Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.1.5 Germany Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
  - 11.2.7.2 France: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.2.1 France: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.2.2 France Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.2.2.1 France Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.2.2.2 France Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.2.3 France Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.2.3.1 France Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.2.4 France Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.2.5 France Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
  - 11.2.7.3 UK: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.3.1 UK: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.3.2 UK, Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.3.2.1 UK, Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.3.2.2 UK, Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.3.3 UK, Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.3.3.1 UK, Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.3.4 UK, Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.3.5 UK, Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
  - 11.2.7.4 Italy: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.4.1 Italy: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.4.2 Italy Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.4.2.1 Italy Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.4.2.2 Italy Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.4.3 Italy Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.4.3.1 Italy Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.4.4 Italy Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.4.5 Italy Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
  - 11.2.7.5 Spain: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.5.1 Spain: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.5.2 Spain Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.5.2.1 Spain Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.5.2.2 Spain Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.5.3 Spain Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.5.3.1 Spain Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.5.4 Spain Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.5.5 Spain Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
  - 11.2.7.6 Rest of Europe: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.6.1 Rest of Europe: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.6.2 Rest of Europe Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.6.2.1 Rest of Europe Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.6.2.2 Rest of Europe Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.6.3 Rest of Europe Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.6.3.1 Rest of Europe Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.6.4 Rest of Europe Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
    - 11.2.7.6.5 Rest of Europe Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
11.3 Asia Pacific: Embolotherapy Market
- 11.3.1 Overview
- 11.3.2 Asia Pacific: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
- 11.3.3 Asia Pacific: Embolotherapy Market, by Product, - Revenue and Forecast to 2028 (US$ Million)
  - 11.3.3.1 Asia Pacific Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
  - 11.3.3.2 Asia Pacific Embolotherapy Market, by Support Device - Revenue and Forecast to 2028 (US$ Million)
- 11.3.4 Asia Pacific Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
  - 11.3.4.1 Asia Pacific Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
  - 11.3.4.2 Asia Pacific Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
- 11.3.5 Asia Pacific: Embolotherapy Market, by End User- Revenue and Forecast to 2028 (US$ Million)
- 11.3.6 Asia Pacific: Embolotherapy Market, by Country, 2022 & 2028 (%)
  - 11.3.6.1 China: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.3.6.1.1 Overview
    - 11.3.6.1.2 China: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.3.6.1.3 China Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    - 11.3.6.1.3.1 China Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
    - 11.3.6.1.3.2 China Embolotherapy Market, by Support Device - Revenue and Forecast to 2028 (US$ Million)
    - 11.3.6.1.4 China Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
    - 11.3.6.1.4.1 China Embolotherapy Market, by Cancer - Revenue and Forecast to 2028 (US$ Million)
    - 11.3.6.1.5 China Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
    - 11.3.6.1.6 China Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
  - 11.3.6.2 Japan: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.3.6.2.1 Japan: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.3.6.2.2 Japan Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    - 11.3.6.2.2.1 Japan Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
    - 11.3.6.2.2.2 Japan Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
    - 11.3.6.2.3 Japan Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
    - 11.3.6.2.3.1 Japan Embolotherapy Market, by Cancer- Revenue and Forecast to 2028 (US$ Million)
    - 11.3.6.2.4 Japan Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
    - 11.3.6.2.5 Japan Embolotherapy Market, By End User- Revenue and Forecast to 2028 (US$ Million)
  - 11.3.6.3 India: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.3.6.3.1 Overview
    - 11.3.6.3.2 India: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.3.6.3.3 India: Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    - 11.3.6.3.3.1 India: Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
    - 11.3.6.3.3.2 India: Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
    - 11.3.6.3.4 India: Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
    - 11.3.6.3.4.1 India: Embolotherapy Market, by Cancer- Revenue and Forecast to 2028 (US$ Million)
    - 11.3.6.3.5 India: Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
    - 11.3.6.3.6 India: Embolotherapy Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  - 11.3.6.4 South Korea: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.3.6.4.1 Overview
    - 11.3.6.4.2 South Korea: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.3.6.4.3 South Korea: Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    - 11.3.6.4.3.1 South Korea: Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
    - 11.3.6.4.3.2 South Korea: Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
    - 11.3.6.4.4 South Korea: Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
    - 11.3.6.4.4.1 South Korea: Embolotherapy Market, by Cancer- Revenue and Forecast to 2028 (US$ Million)
    - 11.3.6.4.5 South Korea: Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
    - 11.3.6.4.6 South Korea: Embolotherapy Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  - 11.3.6.5 Australia: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.3.6.5.1 Overview
    - 11.3.6.5.2 Australia: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.3.6.5.3 Australia: Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    - 11.3.6.5.3.1 Australia: Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
    - 11.3.6.5.3.2 Australia: Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
    - 11.3.6.5.4 Australia: Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
    - 11.3.6.5.4.1 Australia: Embolotherapy Market, by Cancer- Revenue and Forecast to 2028 (US$ Million)
    - 11.3.6.5.5 Australia: Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
    - 11.3.6.5.6 Australia: Embolotherapy Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  - 11.3.6.6 Rest of Asia Pacific: Embolotherapy Market Revenue and Forecast to 2028 (US$ Million)
    - 11.3.6.6.1 Overview
    - 11.3.6.6.2 Rest of Asia Pacific: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.3.6.6.3 Rest of Asia Pacific: Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    - 11.3.6.6.3.1 Rest of Asia Pacific: Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
    - 11.3.6.6.3.2 Rest of Asia Pacific: Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
    - 11.3.6.6.4 Rest of Asia Pacific: Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
    - 11.3.6.6.4.1 Rest of Asia Pacific: Embolotherapy Market, by Cancer- Revenue and Forecast to 2028 (US$ Million)
    - 11.3.6.6.5 Rest of Asia Pacific: Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
    - 11.3.6.6.6 Rest of Asia Pacific: Embolotherapy Market, by End User- Revenue and Forecast to 2028 (US$ Million)
11.4 Middle East & Africa: Embolotherapy Market
- 11.4.1 Overview
- 11.4.2 Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
- 11.4.3 Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)
  - 11.4.3.1 Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)
  - 11.4.3.2 Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)
- 11.4.4 Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)
  - 11.4.4.1 Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)
- 11.4.5 Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)
- 11.4.6 Middle East & Africa: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)
- 11.4.7 Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, By Country (%)
  - 11.4.7.1 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.4.7.1.1 Overview
    - 11.4.7.1.2 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.4.7.1.3 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)
    - 11.4.7.1.3.1 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)
    - 11.4.7.1.3.2 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)
    - 11.4.7.1.4 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)
    - 11.4.7.1.4.1 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)
    - 11.4.7.1.5 Saudi Arabia: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)
    - 11.4.7.1.6 Saudi Arabia: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)
  - 11.4.7.2 South Africa: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.4.7.2.1 Overview
    - 11.4.7.2.2 South Africa: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.4.7.2.3 South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)
    - 11.4.7.2.3.1 South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)
    - 11.4.7.2.3.2 South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)
    - 11.4.7.2.4 South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)
    - 11.4.7.2.4.1 South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)
    - 11.4.7.2.5 South Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)
    - 11.4.7.2.6 South Africa: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)
  - 11.4.7.3 UAE: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.4.7.3.1 Overview
    - 11.4.7.3.2 UAE: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.4.7.3.3 UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)
    - 11.4.7.3.3.1 UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)
    - 11.4.7.3.3.2 UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)
    - 11.4.7.3.4 UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)
    - 11.4.7.3.4.1 UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)
    - 11.4.7.3.5 UAE: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)
    - 11.4.7.3.6 UAE: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)
  - 11.4.7.4 Rest of Middle East and Africa: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.4.7.4.1 Overview
    - 11.4.7.4.2 Rest of Middle East and Africa: Embolotherapy Market Revenue and Forecasts to 2028 (US$ Million)
    - 11.4.7.4.3 Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Product (US$ Million)
    - 11.4.7.4.3.1 Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Embolic Agents (US$ Million)
    - 11.4.7.4.3.2 Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Support Devices (US$ Million)
    - 11.4.7.4.4 Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Disease Indication (US$ Million)
    - 11.4.7.4.4.1 Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Cancer (US$ Million)
    - 11.4.7.4.5 Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecasts to 2028, by Procedure (US$ Million)
    - 11.4.7.4.6 Rest of Middle East & Africa: Embolotherapy Market Revenue and Forecast to 2028, By End User (US$ Million)
11.5 South and Central America: Embolotherapy Market
- 11.5.1 Overview
- 11.5.2 South and Central America: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
- 11.5.3 South and Central America Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
  - 11.5.3.1 South and Central America Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
  - 11.5.3.2 South and Central America Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
- 11.5.4 South and Central America Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
  - 11.5.4.1 South and Central America Embolotherapy Market, by Cancer- Revenue and Forecast to 2028 (US$ Million)
- 11.5.5 South and Central America Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
- 11.5.6 South and Central America Embolotherapy Market, by End User- Revenue and Forecast to 2028 (US$ Million)
- 11.5.7 South and Central America: Embolotherapy Market, by Country, 2022 & 2028 (%)
  - 11.5.7.1 Brazil: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.5.7.1.1 Brazil: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.5.7.1.2 Brazil Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    - 11.5.7.1.2.1 Brazil Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
    - 11.5.7.1.2.2 Brazil Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
    - 11.5.7.1.3 Brazil Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
    - 11.5.7.1.3.1 Brazil Embolotherapy Market, by Cancer- Revenue and Forecast to 2028 (US$ Million)
    - 11.5.7.1.4 Brazil Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
    - 11.5.7.1.5 Brazil Embolotherapy Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  - 11.5.7.2 Argentina: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.5.7.2.1 Argentina: Embolotherapy Market - Revenue and Forecast to 2028 (US$ Million)
    - 11.5.7.2.2 Argentina Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    - 11.5.7.2.2.1 Argentina Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
    - 11.5.7.2.2.2 Argentina Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
    - 11.5.7.2.3 Argentina Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
    - 11.5.7.2.3.1 Argentina Embolotherapy Market, by Cancer- Revenue and Forecast to 2028 (US$ Million)
    - 11.5.7.2.4 Argentina Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
    - 11.5.7.2.5 Argentina Embolotherapy Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  - 11.5.7.3 Rest of South and Central America: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
    - 11.5.7.3.1 Rest of South and Central America: Embolotherapy Market- Revenue and Forecast to 2028 (US$ Million)
    - 11.5.7.3.2 Rest of South and Central America Embolotherapy Market, by Product - Revenue and Forecast to 2028 (US$ Million)
    - 11.5.7.3.2.1 Rest of South and Central America Embolotherapy Market, by Embolic Agents - Revenue and Forecast to 2028 (US$ Million)
    - 11.5.7.3.2.2 Rest of South and Central America Embolotherapy Market, by Support Devices - Revenue and Forecast to 2028 (US$ Million)
    - 11.5.7.3.3 Rest of South and Central America Embolotherapy Market, by Disease Indication - Revenue and Forecast to 2028 (US$ Million)
    - 11.5.7.3.3.1 Rest of South and Central America Embolotherapy Market, by Cancer- Revenue and Forecast to 2028 (US$ Million)
    - 11.5.7.3.4 Rest of South and Central America Embolotherapy Market, by Procedure- Revenue and Forecast to 2028 (US$ Million)
    - 11.5.7.3.5 Rest of South and Central America Embolotherapy Market, by End User- Revenue and Forecast to 2028 (US$ Million)

12. Impact of COVID-19 Pandemic on Global Embolotherapy Market

12.1 North America: Impact Assessment of COVID-19 Pandemic
12.2 Europe: Impact Assessment of COVID-19 Pandemic
12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
12.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
12.5 South & Central America: Impact Assessment of COVID-19 Pandemic

13. Embolotherapy Market -Industry Landscape

13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
- 13.3.1 Overview
13.4 Inorganic Developments
- 13.4.1 Overview

14. Company Profiles

14.1 Abbott Laboratories
- 14.1.1 Key Facts
- 14.1.2 Business Description
- 14.1.3 Products and Services
- 14.1.4 Financial Overview
- 14.1.5 SWOT Analysis
- 14.1.6 Key Developments
14.2 Boston Scientific Corporation
- 14.2.1 Key Facts
- 14.2.2 Business Description
- 14.2.3 Products and Services
- 14.2.4 Financial Overview
- 14.2.5 SWOT Analysis
- 14.2.6 Key Developments
14.3 Cook Medical LLC
- 14.3.1 Key Facts
- 14.3.2 Business Description
- 14.3.3 Products and Services
- 14.3.4 Financial Overview
- 14.3.5 SWOT Analysis
- 14.3.6 Key Developments
14.4 Johnson & Johnson
- 14.4.1 Key Facts
- 14.4.2 Business Description
- 14.4.3 Products and Services
- 14.4.4 Financial Overview
- 14.4.5 SWOT Analysis
- 14.4.6 Key Developments
14.5 Medtronic
- 14.5.1 Key Facts
- 14.5.2 Business Description
- 14.5.3 Products and Services
- 14.5.4 Financial Overview
- 14.5.5 SWOT Analysis
- 14.5.6 Key Developments
14.6 Acandis GmbH
- 14.6.1 Key Facts
- 14.6.2 Business Description
- 14.6.3 Products and Services
- 14.6.4 Financial Overview
- 14.6.5 SWOT Analysis
- 14.6.6 Key Developments
14.7 Balt USA LLC
- 14.7.1 Key Facts
- 14.7.2 Business Description
- 14.7.3 Products and Services
- 14.7.4 Financial Overview
- 14.7.5 SWOT Analysis
- 14.7.6 Key Developments
14.8 Stryker Corporation
- 14.8.1 Key Facts
- 14.8.2 Business Description
- 14.8.3 Products and Services
- 14.8.4 Financial Overview
- 14.8.5 SWOT Analysis
- 14.8.6 Key Developments
14.9 Guerbet LLC
- 14.9.1 Key Facts
- 14.9.2 Business Description
- 14.9.3 Products

塞栓療法市場の2028年までの予測-製品、疾患適応、施術、エンドユーザー別の世界分析

Embolotherapy Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product, Disease Indication, Procedure, and End User

目次

第1章イントロダクション

第2章塞栓療法市場-主要なポイント

第3章調査手法

第4章世界の塞栓療法市場- 市場情勢

第5章塞栓療法市場-主要な市場力学

第6章塞栓療法市場-世界分析

第7章塞栓療法市場の収益と2028年までの製品別予測

第8章塞栓療法市場分析- 疾患適応別

第9章塞栓療法市場の分析- 施術別

第10章塞栓療法市場の分析- エンドユーザー別

第11章塞栓療法市場- 地域別分析

第12章 COVID-19のパンデミックが世界の塞栓療法市場に与える影響

第13章塞栓療法市場-業界情勢

第14章企業プロファイル

List Of Tables

List Of Figures

Reasons to Buy:

Table Of Contents

1. Introduction

2. Embolotherapy Market - Key Takeaways

3. Research Methodology

4. Global Embolotherapy Market - Market Landscape

5. Embolotherapy Market - Key Market Dynamics

6. Embolotherapy Market- Global Analysis

7. Embolotherapy Market Revenue and Forecasts To 2028 by Product

8. Embolotherapy Market Analysis - By Disease Indication

9. Embolotherapy Market Analysis - By Procedure

10. Embolotherapy Market Analysis - By End User

11. Embolotherapy Market - Geographic Analysis

12. Impact of COVID-19 Pandemic on Global Embolotherapy Market

13. Embolotherapy Market -Industry Landscape

14. Company Profiles

塞栓療法市場の2028年までの予測-製品、疾患適応、施術、エンドユーザー別の世界分析

Embolotherapy Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product, Disease Indication, Procedure, and End User

目次

第1章 イントロダクション

第2章 塞栓療法市場-主要なポイント

第3章 調査手法

第4章 世界の塞栓療法市場- 市場情勢

第5章 塞栓療法市場-主要な市場力学

第6章 塞栓療法市場-世界分析

第7章 塞栓療法市場の収益と2028年までの製品別予測

第8章 塞栓療法市場分析- 疾患適応別

第9章 塞栓療法市場の分析- 施術別

第10章 塞栓療法市場の分析- エンドユーザー別

第11章 塞栓療法市場- 地域別分析

第12章 COVID-19のパンデミックが世界の塞栓療法市場に与える影響

第13章 塞栓療法市場-業界情勢

第14章 企業プロファイル

List Of Tables

List Of Figures

Reasons to Buy:

Table Of Contents

1. Introduction

2. Embolotherapy Market - Key Takeaways

3. Research Methodology

4. Global Embolotherapy Market - Market Landscape

5. Embolotherapy Market - Key Market Dynamics

6. Embolotherapy Market- Global Analysis

7. Embolotherapy Market Revenue and Forecasts To 2028 by Product

8. Embolotherapy Market Analysis - By Disease Indication

9. Embolotherapy Market Analysis - By Procedure

10. Embolotherapy Market Analysis - By End User

11. Embolotherapy Market - Geographic Analysis

12. Impact of COVID-19 Pandemic on Global Embolotherapy Market

13. Embolotherapy Market -Industry Landscape

14. Company Profiles

第1章イントロダクション

第2章塞栓療法市場-主要なポイント

第3章調査手法

第4章世界の塞栓療法市場- 市場情勢

第5章塞栓療法市場-主要な市場力学

第6章塞栓療法市場-世界分析

第7章塞栓療法市場の収益と2028年までの製品別予測

第8章塞栓療法市場分析- 疾患適応別

第9章塞栓療法市場の分析- 施術別

第10章塞栓療法市場の分析- エンドユーザー別

第11章塞栓療法市場- 地域別分析

第13章塞栓療法市場-業界情勢

第14章企業プロファイル